275 related articles for article (PubMed ID: 20703888)
1. Hemostatic matrix sealant in neurosurgery: a clinical and imaging study.
Gazzeri R; Galarza M; Neroni M; Alfieri A; Giordano M
Acta Neurochir (Wien); 2011 Jan; 153(1):148-54; discussion 155. PubMed ID: 20703888
[TBL] [Abstract][Full Text] [Related]
2. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in children undergoing adenoidectomy.
Mathiasen RA; Cruz RM
Otolaryngol Head Neck Surg; 2004 Nov; 131(5):601-5. PubMed ID: 15523433
[TBL] [Abstract][Full Text] [Related]
3. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery.
Nasso G; Piancone F; Bonifazi R; Romano V; Visicchio G; De Filippo CM; Impiombato B; Fiore F; Bartolomucci F; Alessandrini F; Speziale G
Ann Thorac Surg; 2009 Nov; 88(5):1520-6. PubMed ID: 19853105
[TBL] [Abstract][Full Text] [Related]
4. Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.
Ellegala DB; Maartens NF; Laws ER
Neurosurgery; 2002 Aug; 51(2):513-5; discussion 515-6. PubMed ID: 12182794
[TBL] [Abstract][Full Text] [Related]
5. Use of a thrombin-gelatin haemostatic matrix in endoscopic endonasal extended approaches: technical note.
Cappabianca P; Esposito F; Esposito I; Cavallo LM; Leone CA
Acta Neurochir (Wien); 2009 Jan; 151(1):69-77; discussion 77. PubMed ID: 19129962
[TBL] [Abstract][Full Text] [Related]
6. Safety biocompatibility of gelatin hemostatic matrix (Floseal and Surgiflo) in neurosurgical procedures.
Gazzeri R; Galarza M; Alfier A
Surg Technol Int; 2012 Dec; 22():49-54. PubMed ID: 22915500
[TBL] [Abstract][Full Text] [Related]
7. Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis.
Mathiasen RA; Cruz RM
Laryngoscope; 2005 May; 115(5):899-902. PubMed ID: 15867662
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma.
Angioli R; Muzii L; Montera R; Damiani P; Bellati F; Plotti F; Zullo MA; Oronzi I; Terranova C; Panici PB
J Minim Invasive Gynecol; 2009; 16(2):153-6. PubMed ID: 19138574
[TBL] [Abstract][Full Text] [Related]
9. Hemostasis in endoscopic sinus surgery using a specific gelatin-thrombin based agent (FloSeal).
Baumann A; Caversaccio M
Rhinology; 2003 Dec; 41(4):244-9. PubMed ID: 14750353
[TBL] [Abstract][Full Text] [Related]
10. Comparison of a new fibrin sealant with standard topical hemostatic agents.
Schwartz M; Madariaga J; Hirose R; Shaver TR; Sher L; Chari R; Colonna JO; Heaton N; Mirza D; Adams R; Rees M; Lloyd D
Arch Surg; 2004 Nov; 139(11):1148-54. PubMed ID: 15545559
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized, controlled trial of a hemostatic sealant in children undergoing adenotonsillectomy.
Jo SH; Mathiasen RA; Gurushanthaiah D
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):454-8. PubMed ID: 17765775
[TBL] [Abstract][Full Text] [Related]
12. Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery.
Fiss I; Danne M; Stendel R
Neurol Med Chir (Tokyo); 2007 Oct; 47(10):462-7. PubMed ID: 17965563
[TBL] [Abstract][Full Text] [Related]
13. Prospective randomized study evaluating an absorbable cyanoacrylate for use in vascular reconstructions.
Lumsden AB; Heyman ER;
J Vasc Surg; 2006 Nov; 44(5):1002-1009; discussion 1009. PubMed ID: 17020801
[TBL] [Abstract][Full Text] [Related]
14. Haemostasis in neurosurgery: what is the evidence for gelatin-thrombin matrix sealant?
Yao HH; Hong MK; Drummond KJ
J Clin Neurosci; 2013 Mar; 20(3):349-56. PubMed ID: 23384508
[TBL] [Abstract][Full Text] [Related]
15. [The use of Floseal in the prevention and treatment of intra- and post-operative hemorrhage in the surgical treatment of hemorrhoids and colporectocele. Preliminary results].
Mongardini M; Pappalardo G
G Chir; 2003 Oct; 24(10):377-81. PubMed ID: 14722999
[TBL] [Abstract][Full Text] [Related]
16. Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant.
Raga F; Sanz-Cortes M; Bonilla F; Casañ EM; Bonilla-Musoles F
Fertil Steril; 2009 Jul; 92(1):356-60. PubMed ID: 19423098
[TBL] [Abstract][Full Text] [Related]
17. Improved hemostasis during laparoscopic partial nephrectomy using gelatin matrix thrombin sealant.
Gill IS; Ramani AP; Spaliviero M; Xu M; Finelli A; Kaouk JH; Desai MM
Urology; 2005 Mar; 65(3):463-6. PubMed ID: 15780356
[TBL] [Abstract][Full Text] [Related]
18. Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal).
Richter F; Schnorr D; Deger S; Trk I; Roigas J; Wille A; Loening SA
Urology; 2003 Jan; 61(1):73-7. PubMed ID: 12559270
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic matrix application after open synovectomy in a hemophilic patient.
García Aríz M; Pérez-Carrasquillo O; Zierenberg CE; Cheleuitte J; Guerra JA; Santiago-Borrero PJ
Am J Orthop (Belle Mead NJ); 2012 Apr; 41(4):179-81. PubMed ID: 22530221
[TBL] [Abstract][Full Text] [Related]
20. Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery.
Doria C; Fischer CP; Wood CG; Li PM; Marra S; Hart J
Curr Med Res Opin; 2008 Mar; 24(3):785-94. PubMed ID: 18241525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]